# Vir Biotechnology, Inc.: Form 8-K, filed Jul 24, 2026

- Company: [Vir Biotechnology, Inc.](/companies/vir.md) (CIK 1706431)
- Form: 8-K
- Filed: 2026-07-24
- Accepted by EDGAR: Jul 24, 2026, 08:31 ET
- Period: 2026-07-20
- Accession: 0001628280-26-049499
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1706431/000162828026049499/vir-20260720.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1706431/000162828026049499/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1706431/000162828026049499/vir-20260720.htm

Filed Jul 24, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-049499. Last ingested by Listed: Nov 3, 2026, 11:08 ET. No prices; not investment advice.